Ceres F&D Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
42
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$3.52M
Ceres F&D General Information
Description
Operator of a biopharmaceutical company intended to develop technology and invest in new medical products. The company specializes in microbial bioactive substances including antibiotics and immunosuppressants, enabling medical practitioners to reduce the risk of organ rejection in patients with allogeneic organ transplantation.
Contact Information
Website
www.ceresfnd.com(Operating Subsidiary)
Corporate Office
- 100, Biovalley 2-ro
- Jecheon, Chumgchungbuk 27159
- South Korea
Corporate Office
- 100, Biovalley 2-ro
- Jecheon, Chumgchungbuk 27159
- South Korea
Ceres F&D Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 01-Nov-2023 | $3.52M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series B) | 14-Feb-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-May-2019 | $2.62M | $3.96M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Feb-2019 | $1.34M | $1.34M | Completed | Generating Revenue |
Ceres F&D Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ceres F&D Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ceres F&D Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| K-Run Ventures | Venture Capital | Minority | ||
| Magna Investment (Seoul) | Venture Capital | Minority | ||
| SJ Investment Partners | Venture Capital | Minority | ||
| Seoul Investment Partners | Venture Capital | Minority |
Ceres F&D Acquisitions (1)
Ceres F&D’s most recent deal was a Merger/Acquisition with GenoTech (Pharmaceutical Materials Division) for . The deal was made on 14-Aug-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| GenoTech (Pharmaceutical Materials Division) | 14-Aug-2018 | Merger/Acquisition | Pharmaceuticals |
Ceres F&D FAQs
-
When was Ceres F&D founded?
Ceres F&D was founded in 2018.
-
Where is Ceres F&D headquartered?
Ceres F&D is headquartered in Jecheon, South Korea.
-
What is the size of Ceres F&D?
Ceres F&D has 42 total employees.
-
What industry is Ceres F&D in?
Ceres F&D’s primary industry is Pharmaceuticals.
-
Is Ceres F&D a private or public company?
Ceres F&D is a Private company.
-
What is the current valuation of Ceres F&D?
The current valuation of Ceres F&D is .
-
What is Ceres F&D’s current revenue?
The current revenue for Ceres F&D is .
-
How much funding has Ceres F&D raised over time?
Ceres F&D has raised $10.7M.
-
Who are Ceres F&D’s investors?
K-Run Ventures, Magna Investment (Seoul), SJ Investment Partners, and Seoul Investment Partners have invested in Ceres F&D.
-
When was Ceres F&D acquired?
Ceres F&D was acquired on 01-Nov-2023.
-
Who acquired Ceres F&D?
Ceres F&D was acquired by NutraSemantics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
